MEI Pharma, Inc.

DB:MMI0 Stock Report

Market Cap: €44.1m

MEI Pharma Management

Management criteria checks 2/4

MEI Pharma's CEO is David Urso, appointed in Jun 2023, has a tenure of less than a year. total yearly compensation is $1.74M, comprised of 29.6% salary and 70.4% bonuses, including company stock and options. directly owns 0.037% of the company’s shares, worth €16.33K. The average tenure of the management team and the board of directors is 1.5 years and 7.8 years respectively.

Key information

David Urso

Chief executive officer

US$1.7m

Total compensation

CEO salary percentage29.6%
CEO tenureless than a year
CEO ownership0.04%
Management average tenure1.5yrs
Board average tenure7.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has David Urso's remuneration changed compared to MEI Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-US$38m

Dec 31 2022n/an/a

-US$31m

Sep 30 2022n/an/a

-US$54m

Jun 30 2022US$2mUS$517k

-US$54m

Mar 31 2022n/an/a

-US$47m

Dec 31 2021n/an/a

-US$64m

Sep 30 2021n/an/a

-US$60m

Jun 30 2021US$2mUS$492k

-US$41m

Mar 31 2021n/an/a

-US$53m

Dec 31 2020n/an/a

-US$31m

Sep 30 2020n/an/a

-US$43m

Jun 30 2020US$1mUS$460k

-US$47m

Mar 31 2020n/an/a

-US$24m

Dec 31 2019n/an/a

-US$38m

Sep 30 2019n/an/a

-US$5m

Jun 30 2019US$1mUS$426k

-US$17m

Mar 31 2019n/an/a

-US$39m

Dec 31 2018n/an/a

-US$28m

Sep 30 2018n/an/a

-US$46m

Jun 30 2018US$1mUS$390k

-US$40m

Mar 31 2018n/an/a

-US$25m

Dec 31 2017n/an/a

-US$20m

Sep 30 2017n/an/a

-US$2m

Jun 30 2017US$671kUS$375k

US$3m

Compensation vs Market: David's total compensation ($USD1.74M) is above average for companies of similar size in the German market ($USD418.12K).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.

CEO

David Urso (59 yo)

less than a year

Tenure

US$1,744,152

Compensation

Mr. David M. Urso, Esq., JD, serves as Chief Executive Officer, President and Director at MEI Pharma, Inc. since June 2, 2023 and had been its Senior Vice President of Corporate Development from March 2014...

Leadership Team

NamePositionTenureCompensationOwnership
David Urso
CEO, President & Directorless than a yearUS$1.74m0.037%
€ 16.3k
Brian Drazba
CFO & Secretary6.3yrsUS$879.66k0.028%
€ 12.4k
Richard Ghalie
Chief Medical Officer7.3yrsUS$1.16m0.022%
€ 9.6k
Eugene Park
Vice President of Marketing1.5yrsno datano data
Anne Frese
Chief People Officer1.1yrsno datano data
Robert Mass
Strategic Advisor12.1yrsUS$755.98k0.025%
€ 11.2k
David Walsey
Senior Vice President of Corporate Affairs2.2yrsno datano data
Yomara Gomez-Naiden
Senior Vice President of Quality1.4yrsno datano data
Justin File
Executive Vice President of Financeless than a yearno datano data

1.5yrs

Average Tenure

62yo

Average Age

Experienced Management: MMI0's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
David Urso
CEO, President & Directorless than a yearUS$1.74m0.037%
€ 16.3k
Tamar Howson
Independent Non-Executive Director4yrsUS$144.60k0%
€ 0
Frederick Driscoll
Independent Non-Executive Director5.4yrsUS$152.10k0.028%
€ 12.4k
Daniel Gold
Director13.3yrsUS$2.53m0.31%
€ 138.3k
Nicholas Glover
Independent Non-Executive Director10.1yrsUS$154.16k0%
€ 0
Sujay Kango
Independent Director1.7yrsUS$124.85k0%
€ 0
Thomas Reynolds
Independent Non-Executive Director10.4yrsUS$144.60k0.0075%
€ 3.3k
Charles Baltic
Independent Non-Executive Chair11.8yrsUS$152.10k0.083%
€ 36.8k

7.8yrs

Average Tenure

63yo

Average Age

Experienced Board: MMI0's board of directors are considered experienced (7.8 years average tenure).